12 research outputs found

    Effect of NIR laser therapy by MLS-MiS source against neuropathic pain in rats: in vivo and ex vivo analysis.

    Get PDF
    Neuropathic pain is characterized by an uncertain etiology and by a poor response to common therapies. The ineffectiveness and the frequent side effects of the drugs used to counteract neuropathic pain call for the discovery of new therapeutic strategies. Laser therapy proved to be effective for reducing pain sensitivity thus improving the quality of life. However, its application parameters and efficacy in chronic pain must be further analyzed. We investigated the pain relieving and protective effect of Photobiomodulation Therapy in a rat model of compressive mononeuropathy induced by Chronic Constriction Injury of the sciatic nerve (CCI). Laser (MLS-MiS) applications started 7 days after surgery and were performed ten times over a three week period showing a reduction in mechanical hypersensitivity and spontaneous pain that started from the first laser treatment until the end of the experiment. The ex vivo analysis highlighted the protective role of laser through the myelin sheath recovery in the sciatic nerve, inhibition of iNOS expression and enhancement of EAAT-2 levels in the spinal cord. In conclusion, this study supports laser treatment as a future therapeutic strategy in patients suffering from neuropathic pain induced by trauma

    Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients

    Get PDF
    Background: The gut-brain axis and the intestinal microbiota are emerging as key players in health and disease. Shifts in intestinal microbiota composition affect a variety of systems; however, evidence of their direct impact on cognitive functions is still lacking. We tested whether faecal microbiota transplant (FMT) from aged donor mice into young adult recipients altered the hippocampus, an area of the central nervous system (CNS) known to be affected by the ageing process and related functions. Results: Young adult mice were transplanted with the microbiota from either aged or age-matched donor mice. Following transplantation, characterization of the microbiotas and metabolomics profiles along with a battery of cognitive and behavioural tests were performed. Label-free quantitative proteomics was employed to monitor protein expression in the hippocampus of the recipients. We report that FMT from aged donors led to impaired spatial learning and memory in young adult recipients, whereas anxiety, explorative behaviour and locomotor activity remained unaffected. This was paralleled by altered expression of proteins involved in synaptic plasticity and neurotransmission in the hippocampus. Also, a strong reduction of bacteria associated with short-chain fatty acids (SCFAs) production (Lachnospiraceae, Faecalibaculum, and Ruminococcaceae) and disorders of the CNS (Prevotellaceae and Ruminococcaceae) was observed. Finally, the detrimental effect of FMT from aged donors on the CNS was confirmed by the observation that microglia cells of the hippocampus fimbria, acquired an ageing-like phenotype; on the contrary, gut permeability and levels of systemic and local (hippocampus) cytokines were not affected. Conclusion: These results demonstrate that age-associated shifts of the microbiota have an impact on protein expression and key functions of the CNS. Furthermore, these results highlight the paramount importance of the gut-brain axis in ageing and provide a strong rationale to devise therapies aiming to restore a young-like microbiota to improve cognitive functions and the declining quality of life in the elderly

    Gc-protein-derived macrophage activating factor counteracts the neuronal damage induced by oxaliplatin

    No full text
    Oxaliplatin-based regimens are effective in metastasized advanced cancers. However, a major limitation to their widespread use is represented by neurotoxicity that leads to peripheral neuropathy. In this study we evaluated the roles of a proven immunotherapeutic agent [Gc-protein-derived macrophage activating factor (GcMAF)] in preventing or decreasing oxaliplatin-induced neuronal damage and in modulating microglia activation following oxaliplatin-induced damage. The effects of oxaliplatin and of a commercially available formula of GcMAF [oleic acid-GcMAF (OA-GcMAF)] were studied in human neurons (SH-SY5Y cells) and in human microglial cells (C13NJ). Cell density, morphology and viability, as well as production of cAMP and expression of vascular endothelial growth factor (VEGF), markers of neuron regeneration [neuromodulin or growth associated protein-43 (Gap-43)] and markers of microglia activation [ionized calcium binding adaptor molecule 1 (Iba1) and B7-2], were determined. OA-GcMAF reverted the damage inflicted by oxaliplatin on human neurons and preserved their viability. The neuroprotective effect was accompanied by increased intracellular cAMP production, as well as by increased expression of VEGF and neuromodulin. OA-GcMAF did not revert the effects of oxaliplatin on microglial cell viability. However, it increased microglial activation following oxaliplatin-induced damage, resulting in an increased expression of the markers Iba1 and B7-2 without any concomitant increase in cell number. When neurons and microglial cells were co-cultured, the presence of OA-GcMAF significantly counteracted the toxic effects of oxaliplatin. Our results demonstrate that OA-GcMAF, already used in the immunotherapy of advanced cancers, may significantly contribute to neutralizing the neurotoxicity induced by oxaliplatin, at the same time possibly concurring to an integrated anticancer effect. The association between these two powerful anticancer molecules would probably produce the dual effect of reduction of oxaliplatin-induced neurotoxicity, together with possible synergism in the overall anticancer effect

    Acute effects of fasted training on physical performance and training stress in highly-conditioned subjects

    No full text
    Background: Over the years, the effects of fasted training on the performance of competitive and amateur athletes has gathered increasing attention. This is mostly due to the theoretical vantages regarding the greater reliance on fatty acids as the energetic substrate and the increased lipolysis in adipose tissue during exercise in the fasted state. At the same time, fasted training is especially preferred by amateur athletes, since it allows them to train early in the morning before work. Questions/purposes: The present study aims to evaluate the effects of a single training session in fasting conditions on physical performance, body composition, and training stress in competitive athletes. Methods: Twelve competitive male athletes in different sports were firstly scored for anthropometric measurements (weight, height, BMI), body composition (Bioelectrical Impedance Analysis, BIA, Akern srl, Italy), salivary cortisol levels (Immunoenzymatic Assay, Diametra srl, Italy), the velocity at maximal oxygen uptake (treadmill incremental vV̇O2max test) and maximal dynamic strength by two dif erent exercises, namely 1-RM Repetition Maximum by Brzycki formula in both bench press and lat pull-down with pronated grip. Each subject randomly performed two equal-volume single training sessions both in normal conditions (i.e. no fasting) and after 12-14 hours of fasting. During the training sessions, the Heart Rate and the Ratings of Perceived Exertion (Borg CR10 scale) were monitored both during the training session and at the end of each session. Results: No differences were found between the training session performed either in normal or fasted conditions regarding all the measurements except for the Heart Rate in the fi rst 5 minutes of aerobic exercise (-3,2% in fasted training, p<0.05) and the lat pull-down maximal strength test (-19% in fasted training, p<0.05); after the training session, salivary cortisol levels were 49% higher in fasted state compared with no fasted condition, though being not statistically significant (p=0.07); with reference to BIA variables, the phase angle showed a slight but significant decrease (-1.3%, p<0.05) at the end of the training session in the fasted conditions, while a minor reduction in the resistance occurred in fasted vs. no fasted training (-1.4%, p<0.05 vs -3.5%, p<0.002, respectively), suggesting a higher catabolic state. Conclusion: In highly-conditioned subjects, the acute response to a single standard training session in fasting conditions does not show excessive athletic and metabolic body stress but rather induces a reduction of dynamic strength and higher catabolism at the end of the training

    The Cerebellar Dopaminergic System.

    No full text
    In the central nervous system (CNS), dopamine (DA) is involved in motor and cognitive functions. Although the cerebellum is not been considered an elective dopaminergic region, studies attributed to it a critical role in dopamine deficit-related neurological and psychiatric disorders [e.g., Parkinson's disease (PD) and schizophrenia (SCZ)]. Data on the cerebellar dopaminergic neuronal system are still lacking. Nevertheless, biochemical studies detected in the mammalians cerebellum high dopamine levels, while chemical neuroanatomy studies revealed the presence of midbrain dopaminergic afferents to the cerebellum as well as wide distribution of the dopaminergic receptor subtypes (DRD1-DRD5). The present review summarizes the data on the cerebellar dopaminergic system including its involvement in associative and projective circuits. Furthermore, this study also briefly discusses the role of the cerebellar dopaminergic system in some neurologic and psychiatric disorders and suggests its potential involvement as a target in pharmacologic and non-pharmacologic treatments
    corecore